标题
Treatment of systemic juvenile idiopathic arthritis
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-04
DOI
10.1038/s41584-023-01042-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- UnDRESSing Systemic Juvenile Idiopathic Arthritis Lung Disease
- (2023) Edward M. Behrens ARTHRITIS CARE & RESEARCH
- Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic‐Exposed Children With Systemic Juvenile Idiopathic Arthritis
- (2023) Holly Wobma et al. ARTHRITIS CARE & RESEARCH
- HLA–DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis
- (2023) Alison M. Lerman et al. ARTHRITIS CARE & RESEARCH
- Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
- (2023) Deepak Chellapandian et al. Frontiers in Pediatrics
- Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
- (2023) Grant S. Schulert et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants
- (2023) Remco G. A. Erkens et al. Arthritis & Rheumatology
- Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
- (2022) Yoshiya Tanaka et al. Nature Reviews Rheumatology
- Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers
- (2022) Guangbo Chen et al. Arthritis & Rheumatology
- Juvenile idiopathic arthritis
- (2022) Alberto Martini et al. Nature Reviews Disease Primers
- Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial
- (2022) Joachim Gerss et al. ANNALS OF THE RHEUMATIC DISEASES
- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
- (2022) Karen B. Onel et al. Arthritis & Rheumatology
- The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
- (2022) Bryce A. Binstadt et al. Arthritis & Rheumatology
- Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
- (2022) William G. Ambler et al. ANNALS OF MEDICINE
- OP0194 COMBINATION ANAKINRA AND TOCILIZUMAB TO TREAT REFRACTORY MACROPHAGE ACTIVATION SYNDROME TRIGGERED BY ADULT-ONSET STILL’S DISEASE.
- (2022) E. Alveyn et al. ANNALS OF THE RHEUMATIC DISEASES
- What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?
- (2022) Nicholas J. Fordham et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18
- (2022) Julia E. Rood et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care
- (2022) Prasad T. Oommen et al. CLINICAL IMMUNOLOGY
- First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
- (2022) Timothy Beukelman et al. Pediatric Rheumatology
- mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
- (2022) Zhengping Huang et al. Nature Communications
- Aberrant naive CD4+ T cell differentiation in systemic juvenile idiopathic arthritis is committed to B cell help
- (2022) Julia Kuehn et al. Arthritis & Rheumatology
- Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis
- (2021) Guillaume Morelle et al. Pediatric Rheumatology
- Refractory systemic juvenile idiopathic arthritis successfully treated with rapamycin
- (2021) Sara Concha et al. RHEUMATOLOGY
- A dysregulated interleukin-18–interferon-γ–CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis
- (2021) Tanja Hinze et al. RHEUMATOLOGY
- Biological classification of childhood arthritis: roadmap to a molecular nomenclature
- (2021) Peter A. Nigrovic et al. Nature Reviews Rheumatology
- Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data
- (2021) Rosemary G. Peterson et al. Pediatric Rheumatology
- Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
- (2021) Remco Erkens et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Interfering with Interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
- (2021) Emely L Verweyen et al. RHEUMATOLOGY
- Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study
- (2021) Christoph Kessel et al. Lancet Rheumatology
- Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
- (2021) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever
- (2021) Carolin Park et al. RHEUMATOLOGY
- Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
- (2020) Brigitte Bader-Meunier et al. ANNALS OF THE RHEUMATIC DISEASES
- Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
- (2020) Scott W. Canna et al. Pediatric Rheumatology
- Early treatment and il1rn snps affect response to anakinra in systemic juvenile idiopathic arthritis
- (2020) Manuela Pardeo et al. Arthritis & Rheumatology
- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes
- (2019) Erika Van Nieuwenhove et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis
- (2019) Faekah Gohar et al. ANNALS OF THE RHEUMATIC DISEASES
- Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics
- (2019) Priyankar Pal et al. INDIAN JOURNAL OF PEDIATRICS
- IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
- (2019) Shima Yasin et al. RHEUMATOLOGY
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Innately adaptive or truly autoimmune
- (2019) Christoph Kessel et al. Arthritis & Rheumatology
- Synergistic TLR/IFNα/β-Signaling Facilitates Escape of IL-18 Expression from Endotoxin Tolerance
- (2019) Emely Verweyen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- Impact of IL1RN variants on response to interleukin‐1 blocking therapy in systemic juvenile idiopathic arthritis
- (2019) Claas Hinze et al. Arthritis & Rheumatology
- Systemic juvenile idiopathic arthritis and macrophage activation syndrome
- (2018) Shima Yasin et al. CURRENT OPINION IN RHEUMATOLOGY
- Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany
- (2018) Claas H. Hinze et al. Pediatric Rheumatology
- Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis
- (2018) Nienke M. ter Haar et al. Arthritis & Rheumatology
- IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
- (2018) Victoria L. Arthur et al. Arthritis & Rheumatology
- T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells
- (2018) Aakanksha Jain et al. Nature Communications
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
- (2018) Alberto Martini et al. JOURNAL OF RHEUMATOLOGY
- Cutting Edge: Distinct Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β
- (2017) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013
- (2016) Jens Klotsche et al. Arthritis & Rheumatology
- HLA-DRB1*11and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
- (2015) Michael J. Ombrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
- (2014) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C
- (2014) Sarah Ringold et al. ARTHRITIS CARE & RESEARCH
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Thalidomide for systemic onset juvenile idiopathic arthritis
- (2013) K. Sathe et al. INDIAN PEDIATRICS
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis
- (2012) Dirk Holzinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
- (2012) Masaki Shimizu et al. CYTOKINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- Teratogenic effects of thalidomide: molecular mechanisms
- (2011) Takumi Ito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial
- (2010) Dirk Foell JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
- (2009) J Narvaez et al. ANNALS OF THE RHEUMATIC DISEASES
- The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis
- (2009) Michael Frosch et al. ARTHRITIS AND RHEUMATISM
- Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report
- (2009) M. Kasher-Meron et al. RHEUMATOLOGY
- S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin
- (2008) Helmut Wittkowski et al. ARTHRITIS AND RHEUMATISM
- Thalidomide: Mechanisms of Action
- (2008) Taraneh Paravar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now